
The episode explores the rapid convergence of organoid technology and artificial intelligence, highlighting how AI-driven image analysis, multidimensional data integration, and high‑throughput screening are transforming organoid research. It introduces the emerging field of Organoid Intelligence, where brain organoids act as biological processors interfaced with AI to create hybrid bio‑computing systems. The discussion also covers precision medicine applications, such as patient‑specific disease modeling, cancer immunotherapy optimization, and drug discovery acceleration, while noting key challenges like scaling organoids, ethical concerns, and data complexity. Several pioneering biotech companies—28Bio, Cortical Labs, Vivodyne, BrainStorm Therapeutics, Curi Bio, PATH Biotech, RUMI Scientific, OrganAId, and ALP AI—are showcased for their AI‑enabled organoid platforms.

The episode highlights Proscia’s recent achievements, including being named the Global 2026 Best in KLAS for Digital Pathology in Europe and a series of product and partnership milestones such as new AI tools for skin biomarkers, virtual staining, and integration...

The episode explores how AI and machine learning are reshaping blood glucose monitoring, moving from invasive blood draws toward non‑invasive analysis of sweat, saliva, and interstitial fluid. It highlights advances such as Raman spectroscopy combined with AI to interpret complex...

This episode highlights four major tech‑bio developments: Egypt’s Nawah Scientific secured $23 million to expand its remote "cloud lab" platform into Rwanda and Saudi Arabia while scaling operations in Egypt; UpCloud opened a new data center in Copenhagen to boost low‑latency...

Egyptian research platform Nawah Scientific announced a $23 million Series A round, led by Life Ventures Holding with participation from Den Venture, Empire M, AfricInvest and Elsewedy. The funding, a mix of equity and debt, will support the launch of a research...

The episode highlights four major tech‑bio developments: LatchBio’s launch of agent.bio, an interactive sandbox for spatial biology analysis across five platforms; Chai Discovery’s $130 M Series B raise to build an AI‑driven CAD suite for drug design, backed by OpenAI; Accenture Ventures’...